Proton Therapy Publication Proton Therapy Publication
Menu

Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia.

April 2021
Executive summary

This MD Anderson study published in the Green Journal retrospectively compares patients with oropharyngeal cancer (OPC) who received IMRT (n = 429) and IMPT (n = 103).

With a median follow-up time of 36.2 months, the study reported that the moderate-severe xerostomia was less common in the IMPT group than in the IMRT group at 18-24 months (6% vs. 20%; p = 0.025) and 24-36 months (6% vs. 20%; p = 0.01).

Key content topics
IMPT
IMRT

Related contents

Proton Therapy Publication
March 2024
Longitudinal Assessment of Quality of Life in Nasopharyngeal Cancer Patients Treated with Intensity-Modulated Proton Therapy and Volumetric Modulated Arc Therapy at Different Time Points.
en
Link to the fully detailed content
Proton Therapy Publication
October 2023
Comparing the oncologic outcomes of proton therapy and intensity-modulated radiation therapy for head and neck squamous cell carcinoma.
en
Link to the fully detailed content
Proton Therapy Publication
pub_3.28
January 2024
Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy.
en
Link to the fully detailed content
Proton Therapy Publication
November 2023
Postmastectomy Intensity Modulated Proton Therapy: 5-Year Oncologic and Patient-Reported Outcomes.
en
Link to the fully detailed content
Webinar
May 8, 2023
Proton Therapy: DynamicARC vs IMPT Treatment Plans & Case Studies
Craig
Stevens
Xuanfeng (Leo)
Ding
Matthew
Hall
Frederic
Genin
Rohan L.
Deraniyagala
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
August 2022
Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
October 2022
High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
October 2022
Systematic Review for Deep Inspiration Breath Hold in Proton Therapy for Mediastinal Lymphoma: A PTCOG Lymphoma Subcommittee Report and Recommendations.
Link to the fully detailed content
Proton Therapy Publication
November 2022
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
en
Link to the fully detailed content